CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN).
2012 ◽
Vol 30
(15_suppl)
◽
pp. CRA9013-CRA9013
Keyword(s):
CRA9013 The full, final text of this abstract will be available at abstract.asco.org at 12:01 AM (EDT) on Monday, June 4, 2012, and in the Annual Meeting Proceedings online supplement to the June 20, 2012, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Monday edition of ASCO Daily News.
2012 ◽
Vol 30
(15_suppl)
◽
pp. CRA3503-CRA3503
◽
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. LBA5002-LBA5002
◽
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. LBA8500-LBA8500
◽
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. LBA4003-LBA4003
Keyword(s):
2013 ◽
Vol 31
(15_suppl)
◽
pp. LBA4004-LBA4004
◽
Keyword(s):
2013 ◽
Vol 31
(15_suppl)
◽
pp. LBA4003-LBA4003
◽
2013 ◽
Vol 31
(15_suppl)
◽
pp. LBA10502-LBA10502
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. LBA10008-LBA10008
◽
Keyword(s):
2013 ◽
Vol 31
(15_suppl)
◽
pp. 1-1
◽
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. 4-4
◽
Keyword(s):